SCHEDULE 13G
Statement of Beneficial Ownership
Jasper Therapeutics, Inc. Filed Acc 0001172661-26-005239
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| Armistice Capital, LLC | 123,102 | 9.99% |
| Steven Boyd | 123,102 | 9.99% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Stake history · largest stake in each 13D and 13G
Loading xslSCHEDULE_13G_X02/primary_doc.xml…